BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38303205)

  • 21. Unusual presentation of multiple endocrine neoplasia type 2A in a patient with the C634R mutation of the RET-protooncogene.
    Harzallah F; Barlier A; Feki M; Enjalbert A; Slimane H
    Ann Endocrinol (Paris); 2008 Dec; 69(6):523-5. PubMed ID: 18752792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
    Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple endocrine neoplasia type 2A with the identical somatic mutation in medullary thyroid carcinoma and pheochromocytoma without germline mutation at the corresponding site in the RET proto-oncogene.
    Akama H; Noshiro T; Kimura N; Shimizu K; Watanabe T; Shibukawa S; Nakai S; Miura W; Ito S; Miura Y
    Intern Med; 1999 Feb; 38(2):145-9. PubMed ID: 10225670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan.
    Iihara M; Yamashita T; Okamoto T; Kanbe M; Yamazaki K; Egawa S; Yamaguchi K; Obara T
    Jpn J Clin Oncol; 1997 Jun; 27(3):128-34. PubMed ID: 9255265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of RET codonic mutations in the surgical management of medullary thyroid carcinoma in pediatric age multiple endocrine neoplasm type 2 syndromes.
    Spinelli C; Di Giacomo M; Costanzo S; Elisei R; Miccoli P
    J Pediatr Surg; 2010 Aug; 45(8):1610-6. PubMed ID: 20713208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.
    Wells SA; Pacini F; Robinson BG; Santoro M
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3149-64. PubMed ID: 23744408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Total thyroidectomy for hereditary medullary thyroid carcinoma 12 years after correction of Hirschsprung's disease.
    Sasaki Y; Shimotake T; Go S; Iwai N
    Eur J Surg; 2001 Jun; 167(6):467-9. PubMed ID: 11471675
    [No Abstract]   [Full Text] [Related]  

  • 28. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds.
    Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B
    J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medullary thyroid carcinoma in ethnic Chinese with MEN2A: a case report and literature review.
    Sim Y; Yap F; Soo KC; Low Y
    J Pediatr Surg; 2013 Jan; 48(1):e43-6. PubMed ID: 23331839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of multiple endocrine neoplasia type 2A (MEN2A) with a mutation in the RET gene].
    Ishizu K; Shiraishi K; Kawamura H; Naito K; Takahashi T; Yoshimura K; Tangoku A; Shirahama S
    Hinyokika Kiyo; 1999 Jun; 45(6):407-10. PubMed ID: 10442282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A MEN2A family with two asymptomatic carriers affected by unilateral renal agenesis.
    Hibi Y; Ohye T; Ogawa K; Shimizu Y; Shibata M; Kagawa C; Mizuno Y; Kurahashi H; Iwase K
    Endocr J; 2014; 61(1):19-23. PubMed ID: 24152999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic thyroidectomy in pediatric carriers of multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma: mutation in C620 is associated with Hirschsprung's disease.
    Bütter A; Gagné J; Al-Jazaeri A; Emran MA; Deal C; St-Vil D
    J Pediatr Surg; 2007 Jan; 42(1):203-6. PubMed ID: 17208566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients.
    Long KL; Etzel C; Rich T; Hyde S; Perrier ND; Graham PH; Lee JE; Hu MI; Cote GJ; Gagel R; Grubbs EG
    Fam Cancer; 2017 Apr; 16(2):283-289. PubMed ID: 27864651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].
    de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT
    Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The clinical patterns and RET proto-oncogene in fifteen multiple endocrine neoplasia type 2A pedigrees].
    Zhou YL; Zhu SX; Li JJ; Liu JB; Yin M; Xiao BY; Yu CL; Wang LM; Gu LQ; Cui B; Ning G; Li XY; Zhao YJ
    Zhonghua Nei Ke Za Zhi; 2007 Jun; 46(6):466-70. PubMed ID: 17663821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The treatment of medullary thyroid cancer].
    Fujita T; Fujimori M
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1627-31. PubMed ID: 19838021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timing and extent of surgery in patients with familial medullary thyroid carcinoma/multiple endocrine neoplasia 2A-related RET mutations not affecting codon 634.
    Gimm O; Ukkat J; Niederle BE; Weber T; Thanh PN; Brauckhoff M; Niederle B; Dralle H
    World J Surg; 2004 Dec; 28(12):1312-6. PubMed ID: 15517481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple endocrine neoplasia type 2A: case report.
    Păun DL; Poiană C; Petriş R; Radian S; Miulescu RD; Constantinescu G; Orban C
    Chirurgia (Bucur); 2013; 108(6):900-3. PubMed ID: 24331334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germ line mutation analysis in families with multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma.
    Karga HJ; Karayianni MK; Linos DA; Tseleni SC; Karaiskos KD; Papapetrou PD
    Eur J Endocrinol; 1998 Oct; 139(4):410-5. PubMed ID: 9820617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medullary thyroid cancer with RET V804M mutation: more indolent than expected?
    Frisco NA; Gunn AH; Thomas SM; Stang MT; Scheri RP; Kazaure HS
    Surgery; 2023 Jan; 173(1):260-267. PubMed ID: 36150924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.